Sort   by:  
 Page size 
UnknownNirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses.
Not available
S-EPMC10165354 | biostudies-literature
UnknownAntibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
Not available
S-EPMC11003867 | biostudies-literature
UnknownCOVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
Not available
S-EPMC8483992 | biostudies-literature
Sort   by:  
 Page size